Jing Zhang

Ms. Jing Zhang

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
XJXia Jiang
Xia Jiang
ZZZiwen Zhang
Ziwen Zhang
JZJiawei Zuo
Jiawei Zuo
CWChengyao Wu
Chengyao Wu
LZLiang Zha
Liang Zha
WTWenjian Tang
Wenjian Tang

2 June 2017 in MedChemComm
Verified
Journal Article
Closed access
PDF file
BLBo Li
Bo Li
YYYongan Yang
Yongan Yang
LCLiuzeng Chen
Liuzeng Chen
SCShichao Chen
Shichao Chen
JZJing Zhang
Jing Zhang
WTWenjian Tang
Wenjian Tang
Based on the SAR analysis of glycyrrhizin, 18α-glycyrrhetinic acid monoglucuronide (18α-GAMG) with strong inhibition against LPS-induced NO and IL-6 production in RAW264.7 cells was discovered. Western blotting and immunofluorescence results showed that 18α-GAMG reduced the expression of iNOS, COX-2, and MAPKs, as well as activation of NF-κB in the LPS-stimulated RAW264.7 cells. Further in vivo results showed that 18α-GAMG could significantly improve the pathological changes of CCl4-induced hepatic fibrosis.

31 March 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
LZLiang Zha
Liang Zha
YXYunfeng Xie
Yunfeng Xie
CWChengyao Wu
Chengyao Wu
MLMing Lei
Ming Lei
XLXueer Lu
Xueer Lu
JZJing Zhang
Jing Zhang

6 July 2022 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
XZXiao-Li Zhang
Xiao-Li Zhang
BLBo Li
Bo Li
XZXiang Zhang
Xiang Zhang
JZJiaojiao Zhu
Jiaojiao Zhu
YXYunfeng Xie
Yunfeng Xie
JZJing Zhang
Jing Zhang
Carbon nanotubes (CNTs) have become far and wide used in a number of technical and merchant applications as a result of substantial advances in nanotechnology, therein single-walled carbon nanotubes (SWCNT) are one of the most promising nanoparticles. Inhaling CNTs has been linked to a variety of health problems, including lung fibrosis. Glycyrrhetinic acid 3-O-mono-β-D-glucuronide (GAMG), a natural sweetener, has anti-inflammatory and antioxidant capacities. The purpose of this study was to evaluate the potential for GAMG to alleviate SWCNT-induced lung inflammation and fibrosis. During days 3-28 after SWCNT intratracheal administration, we observed a remarkable increase of IL-1β, IL-6 and TNF-α in bronchoalveolar lavage fluid (BALF) on day 3 and collagen deposition on day 28. GAMG treatment remarkably ameliorated SWCNT-induced pulmonary fibrosis and attenuated SWCNT-induced inflammation and collagen deposition, and suppressed the activation of PI3K/AKT/NF-κB signaling pathway in the lungs. Therefore, GAMG has a therapeutic potential for the treatment of SWCNT-induced pulmonary fibrosis. Targeting PI3K/AKT/NF-κB signaling pathway may be a potential therapeutic approach to treat pulmonary fibrosis in mice with SWCNT.

28 September 2024 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Open access
JZJing Zhang
Jing Zhang
JZJiazhen Zhang
Jiazhen Zhang
ZYZongze Yao
Zongze Yao
WSWei Shao
Wei Shao
YSYuanchao Song
Yuanchao Song
BLBo Li
Bo Li
Silicosis is an occupational disease caused by exposure to silica characterized by pulmonary inflammation and fibrosis, for which there is a lack of effective drugs. Glycyrrhetinic acid 3-O-β-D-glucuronide (GAMG) can treat silicosis due to its anti-inflammatory and anti-fibrotic properties. Here, the effect of therapeutic interventions of GAMG was evaluated in early-stage and advanced silicosis mouse models. GAMG significantly improved fibrotic pathological changes and collagen deposition in the lungs, alleviated lung inflammation in the BALF, reduced the expression of TNF-α, IL-6, NLRP3, TGF-β1, vimentin, Col-Ⅰ, N-cadherin, and inhibited epithelial-mesenchymal transition (EMT), thereby ameliorating pulmonary fibrosis. Moreover, the dose of 100 mg/kg GAMG can effectively prevent early-stage silicosis, while that of 200 mg/kg was recommended for advanced silicosis. In vitro and in vivo study verified that GAMG can suppress EMT through the NLRP3/TGF-β1/Smad2/3 signaling pathway. Therefore, GAMG could be a promising preventive (early-stage silicosis) and therapeutic (advanced silicosis) strategy, which provides a new idea for formulating prevention and treatment strategies.

18 March 2024 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
QYQianqian Ye
Qianqian Ye
CGChangqin Gui
Changqin Gui
DJDi Jin
Di Jin
JZJiazhen Zhang
Jiazhen Zhang
JZJing Zhang
Jing Zhang
LXLi Xu
Li Xu
Dasatinib-related resistance frequently occurs and may lead to the failure of chemotherapy; thus, dose interruptions are necessary. Cannabidiol (CBD) has potential for integration with orthodox cancer care. In this study, we explored the combination effect of CBD and dasatinib on A549 cells. CBD in combination with dasatinib could induce significant synergistic apoptosis in vitro (ZIP > 10) and in vivo. The combination of CBD and low-dose dasatinib exhibited antiproliferative and proapoptotic effects through up-regulation of caspase-3 and Bax, and down-regulation of Bcl-2 in A549 cells. The xenograft mouse model suggested that the combination was more efficient and safer. In short, CBD and low-dose dasatinib exhibited a synergistic effect on anticancer by targeting the SRC/PI3K/AKT signaling pathway, suggesting a potential therapeutic option for the treatment of lung cancer.